Similar articles

Abstract: cardiac ankyrin repeat protein (CARP) not only serves as an important component of muscle sarcomere in the cytoplasm, but also acts as a transcription co-factor in the nucleus. Previous studies have demonstrated that CARP is up-regulated in some cardiovascular disorders and muscle diseases; however, its role in these diseases remains controversial now. In this review, we will discuss the continued progress in the research related to CARP, including its discovery, structure, and the role it plays in cardiac development and heart diseases.

The authors discuss the discovery structure of ankyrin repeat protein . They also discuss the role of this protein in cardiac development and heart disease. It is a very concise and well organized review providing useful information about this protein to readers. This review was written by standard English and the logic is very clear and easy to follow.

心锚重复蛋白的研究进展

[1]Aihara, Y., Kurabayashi, M., Arai, M., et al., 1999. Molecular cloning of rabbit CARP cDNA and its regulated expression in adriamycin-cardiomyopathy. Biochim. Biophys. Acta, 1447(2-3):318-324.

[2]Aihara, Y., Kurabayashi, M., Saito, Y., et al., 2000a. Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter. Hypertension, 36(1):48-53.

[3]Aihara, Y., Kurabayashi, M., Tanaka, T., et al., 2000b. Doxorubicin represses CARP gene transcription through the generation of oxidative stress in neonatal rat cardiac myocytes: possible role of serine/threonine kinase-dependent pathways. J. Mol. Cell. Cardiol., 32(8):1401-1414.

[4]Arber, S., Hunter, J.J., Ross, J.Jr., et al., 1997. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell, 88(3):393-403.

[5]Aries, A., Paradis, P., Lefebvre, C., et al., 2004. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. PNAS, 101(18):6975-6980.

[6]Arimura, T., Bos, J.M., Sato, A., et al., 2009. Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol., 54(4):334-342.

[7]Bang, M.L., Mudry, R.E., McElhinny, A.S., et al., 2001. Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies. J. Cell Biol., 153(2):413-428.

[8]Bang, M.L., Gu, Y., Dalton, N.D., et al., 2014. The muscle ankyrin repeat proteins CARP, Ankrd2, and DARP are not essential for normal cardiac development and function at basal conditions and in response to pressure overload. PLoS ONE, 9(4):e93638.

[9]Barash, I.A., Mathew, L., Ryan, A.F., et al., 2004. Rapid muscle-specific gene expression changes after a single bout of eccentric contractions in the mouse. Am. J. Physiol. Cell. Physiol., 286(2):C355-C364.

[10]Baumeister, A., Arber, S., Caroni, P., 1997. Accumulation of muscle ankyrin repeat protein transcript reveals local activation of primary myotube endcompartments during muscle morphogenesis. J. Cell Biol., 139(5):1231-1242.

[11]Boengler, K., Pipp, F., Fernandez, B., et al., 2003. Arteriogenesis is associated with an induction of the cardiac ankyrin repeat protein (carp). Cardiovasc. Res., 59(3):573-581.

[12]Bristow, M.R., Billingham, M.E., Mason, J.W., et al., 1978. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat. Rep., 62(6):873-879.

[13]Carson, J.A., Nettleton, D., Reecy, J.M., 2002. Differential gene expression in the rat soleus muscle during early work overload-induced hypertrophy. FASEB J., 16(2):207-209.

[14]Chen, B., Zhong, L., Roush, S.F., et al., 2012. Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy. PLoS ONE, 7(4):e35743.

[15]Chen, C., Shen, L., Cao, S., et al., 2014. Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation. PLoS ONE, 9(8):e104040.

[16]Chien, K.R., Zhu, H., Knowlton, K.U., et al., 1993. Transcriptional regulation during cardiac growth and development. Annu. Rev. Physiol., 55:77-95.

[17]Chu, W., Burns, D.K., Swerlick, R.A., et al., 1995. Identification and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells. J. Biol. Chem., 270(17):10236-10245.

[18]Cinquetti, R., Badi, I., Campione, M., et al., 2008. Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return. Hum. Mutat., 29(4):468-474.

[19]Crocini, C., Arimura, T., Reischmann, S., et al., 2013. Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue. Basic Res. Cardiol., 108(3):349.

[20]Depre, C., Tomlinson, J.E., Kudej, R.K., et al., 2001. Gene program for cardiac cell survival induced by transient ischemia in conscious pigs. PNAS, 98(16):9336-9341.

[21]de Waard, V., van Achterberg, T.A., Beauchamp, N.J., et al., 2003. Cardiac ankyrin repeat protein (CARP) expression in human and murine atherosclerotic lesions: activin induces CARP in smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 23(1):64-68.

[22]Doroshow, J.H., Locker, G.Y., Myers, C.E., 1980. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J. Clin. Invest., 65(1):128-135.

[23]Duboscq-Bidot, L., Charron, P., Ruppert, V., et al., 2009. Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. Eur. Heart J., 30(17):2128-2136.

[24]Evans, T., Rosenthal, E.T., Youngblom, J., et al., 1983. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell, 33(2):389-396.

[25]Frey, N., Olson, E.N., 2003. Cardiac hypertrophy: the good, the bad, and the ugly. Ann. Rev. Physiol., 65:45-79.

[26]Granzier, H.L., Labeit, S., 2004. The giant protein titin: a major player in myocardial mechanics, signaling, and disease. Circ. Res., 94(3):284-295.

[27]Gronostajski, R.M., Goldberg, A.L., Pardee, A.B., 1984. Energy requirement for degradation of tumor-associated protein p53. Mol. Cell. Biol., 4(3):442-448.

[28]Han, X.J., Chae, J.K., Lee, M.J., et al., 2005. Involvement of GADD153 and cardiac ankyrin repeat protein in hypoxia-induced apoptosis of H9c2 cells. J. Biol. Chem., 280(24):23122-23129.

[29]Hentzen, E.R., Lahey, M., Peters, D., et al., 2006. Stress-dependent and -independent expression of the myogenic regulatory factors and the MARP genes after eccentric contractions in rats. J. Physiol., 570(Pt 1):157-167.

[30]Ikeda, K., Emoto, N., Matsuo, M., et al., 2003. Molecular identification and characterization of a novel nuclear protein whose expression is up-regulated in insulin-resistant animals. J. Biol. Chem., 278(6):3514-3520.

[31]Ishiguro, N., Motoi, T., Araki, N., et al., 2008. Expression of cardiac ankyrin repeat protein, CARP, in malignant tumors: diagnostic use of CARP protein immunostaining in rhabdomyosarcoma. Hum. Pathol., 39(11):1673-1679.

[32]Jeyaseelan, R., Poizat, C., Baker, R.K., et al., 1997. A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J. Biol. Chem., 272(36):22800-22808.

[33]Kanai, H., Tanaka, T., Aihara, Y., et al., 2001. Transforming growth factor-β/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells. Circ. Res., 88(1):30-36.

[34]Kim, Y., Ma, A.G., Kitta, K., et al., 2003. Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis. Mol. Pharmacol., 63(2):368-377.

[35]Kuo, H., Chen, J., Ruiz-Lozano, P., et al., 1999. Control of segmental expression of the cardiac-restricted ankyrin repeat protein gene by distinct regulatory pathways in murine cardiogenesis. Development, 126(19):4223-4234.

[36]Labeit, S., Kolmerer, B., Linke, W.A., 1997. The giant protein titin. Emerging roles in physiology and pathophysiology. Circ. Res., 80(2):290-294.

[37]Laure, L., Suel, L., Roudaut, C., et al., 2009. Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling. FEBS J., 276(3):669-684.

[38]Lee, M.J., Kwak, Y.K., You, K.R., et al., 2009. Involvement of GADD153 and cardiac ankyrin repeat protein in cardiac ischemia-reperfusion injury. Exp. Mol. Med., 41(4):243-252.

[39]Lei, Y., Henderson, B.R., Emmanuel, C., et al., 2015. Inhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosis. Oncogene, 34(4):485-495.

[40]Ma, G., Wang, H., Li, Y., et al., 2013. Cloning, expression, and bioinformatics analysis of the sheep CARP gene. Mol. Cell. Biochem., 378(1-2):29-37.

[41]Matsuura, K., Uesugi, N., Hijiya, N., et al., 2007. Upregulated expression of cardiac ankyrin-repeated protein in renal podocytes is associated with proteinuria severity in lupus nephritis. Hum. Pathol., 38(3):410-419.

[42]Miller, M.K., Bang, M.L., Witt, C.C., et al., 2003. The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. J. Mol. Biol., 333(5):951-964.

[43]Miller, M.K., Granzier, H., Ehler, E., et al., 2004. The sensitive giant: the role of titin-based stretch sensing complexes in the heart. Trends Cell Biol., 14(3):119-126.

[44]Moulik, M., Vatta, M., Witt, S.H., et al., 2009. ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. J. Am. Coll. Cardiol., 54(4):325-333.

[45]Nakada, C., Oka, A., Nonaka, I., et al., 2003a. Cardiac ankyrin repeat protein is preferentially induced in atrophic myofibers of congenital myopathy and spinal muscular atrophy. Pathol. Int., 53(10):653-658.

[46]Nakada, C., Tsukamoto, Y., Oka, A., et al., 2003b. Cardiac-restricted ankyrin-repeated protein is differentially induced in duchenne and congenital muscular dystrophy. Lab. Invest., 83(5):711-719.

[47]Rogers, S., Wells, R., Rechsteiner, M., 1986. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science, 234(4774):364-368.

[48]Sadoshima, J., Izumo, S., 1997. The cellular and molecular response of cardiac myocytes to mechanical stress. Ann. Rev. Physiol., 59:551-571.

[49]Scurr, L.L., Guminski, A.D., Chiew, Y.E., et al., 2008. Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer. Clin. Cancer Res., 14(21):6924-6932.

[50]Sedgwick, S.G., Smerdon, S.J., 1999. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem. Sci., 24(8):311-316.

[51]Shen, L., Chen, C., Wei, X., et al., 2015. Overexpression of ankyrin repeat domain 1 enhances cardiomyocyte apoptosis by promoting p53 activation and mitochondrial dysfunction in rodents. Clin. Sci., 128(10):665-678.

[52]Shi, Y., Reitmaier, B., Regenbogen, J., et al., 2005. CARP, a cardiac ankyrin repeat protein, is up-regulated during wound healing and induces angiogenesis in experimental granulation tissue. Am. J. Pathol., 166(1):303-312.

[53]Singal, P.K., Iliskovic, N., 1998. Doxorubicin-induced cardiomyopathy. New Engl. J. Med., 339(13):900-905.

[54]Song, Y., Xu, J., Li, Y., et al., 2012. Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-β signaling pathways. PLoS ONE, 7(12):e50436.

[55]Stam, F.J., MacGillavry, H.D., Armstrong, N.J., et al., 2007. Identification of candidate transcriptional modulators involved in successful regeneration after nerve injury. Eur. J. Neurosci., 25(12):3629-3637.

[56]Steinherz, L.J., Steinherz, P.G., Tan, C.T., et al., 1991. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA, 266(12):1672-1677.

[57]Torrado, M., López, E., Centeno, A., et al., 2004. Left-right asymmetric ventricular expression of CARP in the piglet heart: regional response to experimental heart failure. Eur. J. Heart Fail., 6(2):161-172.

[58]Torrado, M., Nespereira, B., López, E., et al., 2005. ANKRD1 specifically binds CASQ2 in heart extracts and both proteins are co-enriched in piglet cardiac Purkinje cells. J. Mol. Cell. Cardiol., 38(2):353-365.

[59]Torrado, M., Nespereira, B., Bouzamayor, Y., et al., 2006. Differential atrial versus ventricular ANKRD1 gene expression is oppositely regulated at diastolic heart failure. FEBS Lett., 580(17):4182-4187.

[60]Tsukamoto, Y., Senda, T., Nakano, T., et al., 2002. Arpp, a new homolog of carp, is preferentially expressed in type 1 skeletal muscle fibers and is markedly induced by denervation. Lab. Invest., 82(5):645-655.

[61]Witt, C.C., Ono, Y., Puschmann, E., et al., 2004. Induction and myofibrillar targeting of CARP, and suppression of the Nkx2.5 pathway in the MDM mouse with impaired titin-based signaling. J. Mol. Biol., 336(1):145-154.

[62]Yen, H.C., Oberley, T.D., Vichitbandha, S., et al., 1996. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J. Clin. Invest., 98(5):1253-1260.

[63]Zhou, S., Palmeira, C.M., Wallace, K.B., 2001. Doxorubicin-induced persistent oxidative stress to cardiac myocytes. Toxicol. Lett., 121(3):151-157.

[64]Zolk, O., Frohme, M., Maurer, A., et al., 2002. Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem. Biophys. Res. Commun., 293(5):1377-1382.

[65]Zou, Y., Evans, S., Chen, J., et al., 1997. CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway. Development, 124(4):793-804.